This Activity for
- Pharmacy
- Clinical Pharmacy
What I will learn?
•Understand the mechanism of action of Mounjaro, a once-weekly, first-in-class GIP and GLP-1 receptor agonist for chronic weight management and type 2 diabetes.
•Review the efficacy and safety of Mounjaro in chronic weight management and type 2 diabetes.
•Review the efficacy superiority of Tirzepatide compared with Semaglutide in chronic weight management.
•Discuss the safe and effective use of Mounjaro.
•Review the efficacy and safety of Mounjaro in chronic weight management and type 2 diabetes.
•Review the efficacy superiority of Tirzepatide compared with Semaglutide in chronic weight management.
•Discuss the safe and effective use of Mounjaro.
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist for Chronic Weight Management and Type 2 Diabetes Certificate
Certificate |
Certificate | Free |
VAT 15% Included